We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
Cap. Flow
+$1.91B
Cap. Flow %
4.16%
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$127M
2
CI icon
Cigna
CI
+$54M
3
CVS icon
CVS Health
CVS
+$38.8M
4
MPC icon
Marathon Petroleum
MPC
+$28.9M
5
FANG icon
Diamondback Energy
FANG
+$19M

Sector Composition

Rank Sector Weight
1 Technology 16.95%
2 Financials 15.85%
3 Healthcare 14.41%
4 Consumer Discretionary 10.13%
5 Industrials 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARDX icon
2876
Ardelyx
ARDX
$1.21B
$107K ﹤0.01%
59,522
+22,686
+62% +$66.8K
CUE icon
2877
Cue Biopharma
CUE
$112M
$107K ﹤0.01%
760
+258
+51% +$46.8K
MNTX
2878
DELISTED
Manitex International, Inc.
MNTX
$106K ﹤0.01%
18,666
+6,442
+53% +$50K
SREV
2879
DELISTED
ServiceSource International, Inc.
SREV
$104K ﹤0.01%
96,543
+29,383
+44% +$46.3K
GNK icon
2880
Genco Shipping & Trading
GNK
$1.11B
$102K ﹤0.01%
+12,896
New +$131K
TRAK icon
2881
ReposiTrak
TRAK
$156M
$102K ﹤0.01%
17,098
+5,823
+52% +$47.5K
VRDN icon
2882
Viridian Therapeutics
VRDN
$2.33B
$101K ﹤0.01%
2,223
+754
+51% +$43.6K
DWSN icon
2883
Dawson Geophysical
DWSN
$138M
$100K ﹤0.01%
29,555
+9,339
+46% +$44.4K
MBII
2884
DELISTED
Marrone Bio Innovations, Inc.
MBII
$100K ﹤0.01%
68,021
+20,882
+44% +$32K
PFSW
2885
DELISTED
PFSweb, Inc.
PFSW
$100K ﹤0.01%
19,506
+6,728
+53% +$43.3K
DRRX
2886
DELISTED
DURECT Corp
DRRX
$99K ﹤0.01%
20,429
+6,299
+45% +$55K
ROX
2887
DELISTED
Castle Brands, Inc.
ROX
$97K ﹤0.01%
113,675
+37,400
+49% +$34.4K
BBVA icon
2888
Banco Bilbao Vizcaya Argentaria
BBVA
$155B
$96K ﹤0.01%
18,214
CELH icon
2889
Celsius Holdings
CELH
$7.45B
$95K ﹤0.01%
81,900
+27,720
+51% +$34.9K
NATR icon
2890
Nature's Sunshine
NATR
$353M
$95K ﹤0.01%
+11,635
New +$101K
FRAN
2891
DELISTED
Francesca's Holdings Corporation
FRAN
$95K ﹤0.01%
8,176
+1,155
+16% +$33.6K
RJET
2892
Republic Airways Holdings
RJET
$1.01B
$92K ﹤0.01%
+797
New +$148K
TPHS
2893
DELISTED
Trinity Place Holdings Inc.com
TPHS
$92K ﹤0.01%
21,144
+6,010
+40% +$31.5K
FRTA
2894
DELISTED
Forterra, Inc
FRTA
$92K ﹤0.01%
24,417
+7,660
+46% +$39K
PSEC icon
2895
Prospect Capital
PSEC
$1.09B
$89K ﹤0.01%
14,110
+32
+0.2% +$216
CWBR
2896
DELISTED
CohBar, Inc. Common Stock
CWBR
$89K ﹤0.01%
950
+319
+51% +$35.4K
MGI
2897
DELISTED
MoneyGram International, Inc. New
MGI
$89K ﹤0.01%
44,422
+13,437
+43% +$43.2K
NWHM
2898
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$88K ﹤0.01%
16,749
+4,520
+37% +$31.9K
FENC icon
2899
Fennec Pharmaceuticals
FENC
$365M
$87K ﹤0.01%
+13,655
New +$95.4K
SNDX icon
2900
Syndax Pharmaceuticals
SNDX
$1.77B
$86K ﹤0.01%
19,410
+5,350
+38% +$29.3K

Similar funds

RhumbLine Advisers's Q4 2018 Portfolio in Review

As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.

  • RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
  • RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
  • RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
  • RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
  • RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
  • RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.